CRO Business Operations
Sample data

Study Portfolio

Active studies, enrollment progress and milestone risk

Active Studies
48
Patients Enrolled
13,964
Enrollment vs Plan
86%
Below 90% target
High Risk Milestones
3
547 active sites

Active Studies by Phase and Therapeutic Area

Cumulative Enrollment vs Plan

Milestones at Risk

StudyTherapeutic AreaMilestoneDueProjected Slip (days)Risk
MCR-ONC-101OncologyDatabase lockMay 202617Medium
MCR-CAR-108CardiologyFirst patient inFeb 202660Medium
MCR-NEU-115NeurologyCSR deliveryFeb 202662High
MCR-IMM-122ImmunologyCSR deliveryMar 202628Medium
MCR-INF-129Infectious DiseaseCSR deliveryOct 202648Medium
MCR-ONC-136OncologyCSR deliveryJul 202626High
MCR-CAR-143CardiologyInterim analysisOct 202621High